Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Drug and Alcohol Dependence|January 16, 2022
Ulotaront, a novel TAAR1 agonist with 5-HT1A agonist activity, lacks abuse liability and attenuates cocaine cue-induced relapse in ratsColleen Synan, Carrie Bowen, David J Heal, et al.
Cellular and Molecular Neurobiology|December 27, 2011
Assessing behavioural effects of chronic HPA axis activation using conditional CRH-overexpressing miceNina Dedic, Chadi Touma, Cristoph P Romanowski, et al.
Frontiers in Cellular Neuroscience|July 25, 2013
Activation of CRH receptor type 1 expressed on glutamatergic neurons increases excitability of CA1 pyramidal neurons by the modulation of voltage-gated ion channelsStephan Kratzer, Corinna Mattusch, Michael W Metzger, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 19, 2023
TAAR1 agonist ulotaront modulates striatal and hippocampal glutamate function in a state-dependent mannerSung M Yang, Ayan Ghoshal, Jeffrey M Hubbard, et al.
Pharmacology, Biochemistry, and Behavior|November 28, 2024
5-HT<sub>1B</sub> receptor activation produces rapid antidepressant-like effects in rodentsErin A Clark, Lien Wang, Taleen Hanania, et al.
Purinergic Signalling|March 2, 2025
Establishment and behavioural characterization of a novel constitutive P2X7 receptor knockout mouse lineIven-Alex von Mücke-Heim, Judit Oldekamp, Michael W Metzger, et al.
Neuroimage|December 27, 2017
Mn<sup>2+</sup> dynamics in manganese-enhanced MRI (MEMRI): Ca<sub>v</sub>1.2 channel-mediated uptake and preferential accumulation in projection terminalsBenedikt T Bedenk, Suellen Almeida-Corrêa, Angela Jurik, et al.
Cell|June 3, 2017
Noninvasive Deep Brain Stimulation via Temporally Interfering Electric FieldsNir Grossman, David Bono, Nina Dedic, et al.
ACS Medicinal Chemistry Letters|January 20, 2022
Ulotaront: A TAAR1 Agonist for the Treatment of SchizophreniaMichele L R Heffernan, Lee W Herman, Scott Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 3, 2019
SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D<sub>2</sub> Receptor Mechanism of ActionNina Dedic, Philip G Jones, Seth C Hopkins, et al.
Pageof 4